Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35977234.
- Also identified by DOI 10.1001/jamahealthforum.2021.4468 and PMC identifier 8903107.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study uses data from the Centers for Medicare & Medicaid Services to assess the use of professional society guideline-nonconcordant radiotherapy in patients at the end of life.
Medical subject headings
- Medicare
- Neoplasms